Literature DB >> 3139464

Antiphospholipid antibodies in early repeated abortions: a case-controlled study.

T Barbui1, S Cortelazzo, M Galli, F Parazzini, E Radici, E Rossi, G Finazzi.   

Abstract

The relation among lupus anticoagulant (LAC), anticardiolipin antibodies (ACA), and repeated abortions was evaluated in a case-controlled study of 49 women with two or more unexplained spontaneous abortions (cases) compared with 141 control subjects, who had had one or more normal pregnancies and no previous spontaneous abortion. The women were admitted to the same hospital where the cases had been identified for acute conditions other than immunologic neoplastic, gynecologic or cardiovascular. LAC was detected in 7 out of 49 cases (14%, 95% confidence limits 8% to 26%) but in none of the 141 controls. Similarly, ACA were detected in four cases (8%, 95% confidence limits 0.3% to 30%) but no controls. These differences in frequency were statistically significant. These findings confirm that LAC and ACA are associated with a history of repeated abortions in clinically asymptomatic patients for immunologic conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139464

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Antiphospholipid antibodies: which and when?

Authors:  R Cervera; J Font; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

2.  Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death.

Authors:  Noura Al Jameil; Poonam Tyagi; Amal Al Shenefy
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Lupus anticoagulants and anticardiolipin antibodies in Indian women with spontaneous, recurrent fetal loss.

Authors:  Akanksha Rawat; Meera Sikka; Usha Rusia; Kiran Guleria
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-08       Impact factor: 0.900

4.  Prevalence of antiphospholipid antibodies in patients with fetal loss.

Authors:  H J Out; H W Bruinse; G C Christiaens; M van Vliet; J F Meilof; P G de Groot; R J Smeenk; R H Derksen
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

5.  Pregnancy outcome in women with antiphospholipid antibodies.

Authors:  A K al-Momen; S A Moghraby; M O el-Rab; A M Gader; S R al-Balla; A A al-Meshari; L al-Nuaim
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.